MAZE: Both director nominees and the auditor appointment were approved by majority vote
At the MAZE annual general meeting, a quorum was confirmed, and proposals for the election of two directors and the ratification of the auditor were a...
At the MAZE annual general meeting, a quorum was confirmed, and proposals for the election of two directors and the ratification of the auditor were a...
Bullish
Maze Therapeutics, Inc. (Nasdaq: MAZE) announced that its CEO, Jason Coloma, Ph.D., will participate in two investor conferences: the 2026 Jefferies G...